Amid $126-mn target, Indian pharma exporters stare at Afghan uncertainty

As uncertainty looms large in Afghanistan, Indian pharma exporters are apprehensive to send goods to the war-torn country

Taliban fighters
Taliban fighters display their flag as they patrol in Kabul, Afghanistan (Photo: AP/PTI)
Press Trust of India Hyderabad
2 min read Last Updated : Aug 24 2021 | 6:08 PM IST

: As uncertainty looms large in Afghanistan, Indian pharma exporters are apprehensive to send goods to the war-torn country and the target of exporting USD 126 million worth of pharmaceutical goods to the Taliban-ruling nation now depends on the future outcome.

Udaya Bhaskar, Director General of Pharmaceuticals Export Promotion Council of India (Pharmexcil) body under the Department of Commerce on Tuesday said as the situation is grim over there and India pharma exporters have cordial relations with Afghanistan.

"The projected target for 2021-22 is USD 126.22 million. The majority of it would be formulations and after that vaccines. Now with the present situation, exporters are apprehensive with regards to how the new regime will act upon. It is too early to comment on export targets," the official told PTI on Tuesday.

He, however, said there was no instruction from the centre to suspend exports to Afghanistan.

According to the statistics supplied by Pharmexicl, India exported nearly USD 90 million and USD 97 worth of pharma products to Afghanistan in 2019-20 and 2020-21 respectively and became the second largest exporter after Pakistan.

Afghanistan has accepted Indian Pharmacopeia and the drugs manufactured in India are accepted there, Udaya Bhaskar said.

"A team of Afghan officials and trade representatives visited and held discussions with their counterparts in India in 2019 stemming the cordial relations," he said.

Federation of Indian Export Organisations (FIEO) Director General Ajay Sahai recently said domestic exporters should follow caution looking into the political development in Afghanistan, particularly with regard to payments, for which adequate credit insurance may be availed by them.

According to a pharma trade expert, Indian pharma exports comprises 20 per cent vaccines. Though Afghanistan does not receive all its required vaccines from India directly, several non-governmental organisations procure them from Indian firms and send them to that country.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :TalibanIndian pharmaPharma exportersAfghanistan

First Published: Aug 24 2021 | 6:08 PM IST

Next Story